Alliance to Zero
Alliance to Zero is a Swiss non-profit membership association founded in 2021 that brings together nine pharmaceutical supply chain companies to collaboratively develop methodologies, guidelines, and product solutions for decarbonizing the pharma sector and achieving net zero emissions.
- Company typePrivate
- Founded2021
- HeadquartersBurgdorf, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Alliance to Zero does
Alliance to Zero is a non-profit membership association founded on June 2, 2021, and headquartered in Burgdorf, Canton of Bern, Switzerland, operating under Articles 60 et seq. of the Swiss Civil Code. The organization serves as a pre-competitive consortium for pharmaceutical and biotech supply chain companies, currently comprising nine member companies: SCHOTT Pharma, Ypsomed, Datwyler, Sharp, Schreiner MediPharm, Körber Pharma, Harro Höfliger, HealthBeacon, and Resourcify. Its stated mission is to facilitate the transition of the pharmaceutical sector to compliance with net zero emissions in line with the Paris Climate Agreement.
The Alliance produces collaborative intellectual outputs and co-developed product solutions rather than commercial products. Its core deliverables include the PCF Guideline (a methodological framework for Product Carbon Footprint assessment of automated disposable injection devices), the 11 Ecodesign Principles for Injection Devices, Ecodesign for Machinery Principles, a Sustainable Plastics Whitepaper examining alternatives to fossil-based plastics, the Net Zero Requires Circularity publication, and the Secure Blister-Free Syringe (SBFS) Solution — a co-developed packaging innovation achieving 80% less plastic and 25% smaller dimensions. The organization actively engages with regulatory bodies, including submitting a consultation statement to the EU Circular Economy Act proposing a new 'Circular Material Use' category in the Waste Hierarchy.
The business model is membership-based: the Alliance is funded by contributions from its member companies rather than commercial product sales or service fees. Its go-to-market centers on industry thought leadership through conference participation (CPHI, Pharmapack, PDA conferences), workshop delivery (notably through a strategic partnership with Informa Markets/CPHI), and free publication of research papers and guidelines. Pricing is not publicly disclosed as the organization does not sell products directly to end customers.
Alliance to Zero firmographics
Firmographics- Name
- Alliance to Zero
- Legal name
- Alliance to Zero
- Website
- https://alliancetozero.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Alliance to Zero is a Swiss non-profit membership association founded in 2021 that brings together nine pharmaceutical supply chain companies to collaboratively develop methodologies, guidelines, and product solutions for decarbonizing the pharma sector and achieving net zero emissions.
- Ownership category
- akta.pro rank
Alliance to Zero industry classification
Industry- Product category
- Pharmaceutical Supply Chain Sustainability Association
- NAICS
- Business Associations (813910), Environmental Consulting Services (54162)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Decarbonization Strategy & Marginal Abatement Cost Curve (MACC) Advisory (EUABAKAC)
- akta.pro secondary industries
- Scope 1–3 GHG Inventory Strategy, Data Governance & Controls (advisory) (EUABAKAD), Net-Zero Target Setting & SBTi/Net-Zero Standard Support (EUABAKAA), Regulatory & Disclosure Strategy (CSRD/ESRS, ISSB/IFRS S2, SEC, TCFD) (EUABAKAH), Circular Economy & Waste/Materials Reporting (Zero waste, packaging) (EUAHAJAL), Net-Zero Assurance & Readiness Assessments (limited assurance prep, audit support) (EUABAKAJ)
Keywords
Where Alliance to Zero is headquartered
LocationHeadquarters
- HQ city
- Burgdorf
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Alliance to Zero business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Distribution channels1 record
Marketing channels8 records
Alliance to Zero product offering
Product offeringCore offering
Alliance to Zero is a non-profit membership association that brings together pharmaceutical and biotech supply chain companies to collaboratively develop methodologies, guidelines, and solutions for decarbonizing the sector. Its deliverables include the PCF Guideline for carbon footprint assessment of injection devices, ecodesign principles for injectors and machinery, circular economy frameworks, whitepapers on sustainable plastics, and co-developed innovations such as the Secure Blister-Free Syringe (SBFS) packaging solution.
Product overview
Alliance to Zero is a non-profit membership association for pharma and biotech supply chain companies, not a traditional product company. The organization produces collaborative sustainability resources including the PCF Guideline (methodological framework for product carbon footprint assessment), Ecodesign Principles Paper (11 principles for sustainable injector device design), Ecodesign for Machinery Principles (machinery-related emissions reduction), Sustainable Plastics Whitepaper (alternatives to fossil-based plastics), Secure Blister-Free Syringe Solution (innovative packaging eliminating blister plastic), and Net Zero Requires Circularity paper. These publications and solutions are developed collectively by member companies to facilitate the pharmaceutical sector's transition to net zero emissions.
Differentiator
Problem solved
Functional benefit
Products and services
- PCF Guideline (Product Carbon Footprint methodology for injection devices)
- Ecodesign Principles Paper (11 principles for injection devices)
- Ecodesign for Machinery Principles
- Sustainable Plastics Whitepaper
- Secure Blister-Free Syringe (SBFS) Solution
- Net Zero Requires Circularity publication
Companies that use Alliance to Zero
Customer profileSegments1 record
Ideal customer profiles1 record
Alliance to Zero technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Alliance to Zero partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Informa Markets / CPHIcoreStrategic partnership with Informa Markets, organizer of CPhI (the world's largest pharmaceutical event platform), for joint workshops, panel discussions, and sustainability track programming. The collaboration includes workshops such as 'Speak the Same Language: Jumpstart Your Understanding of a Sustainable Supply Chain' and joint participation in the Sustainable Futures track at CPhI events.
- Parenteral Drug Association (PDA)coreCollaboration with PDA to host workshops on 'The Circular Economy in Pharma', including a workshop on October 16th prior to the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference in Gothenburg, Sweden.
- ResourcifycoreCircular operating systems company that enables sustainable growth by digitising waste management, data-driven optimisation, and closed loop recycling programs. Joined as the 9th member of Alliance to Zero in June 2025 to contribute expertise in waste management and recycling to accelerate circular concepts for injection devices.
- SharpcoreLeader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing with heritage spanning more than 70 years. Specializes in secondary packaging of injectables. Founding member of Alliance to Zero.
- Harro HöfligercoreTechnology supplier for realizing entire product ideas from laboratory stage to production, specializing in filling, assembly and packaging lines. Founding member representing machine/supplier perspective.
- Schreiner MediPharmcoreLeading developer and manufacturer of innovative, multifunctional specialty labels and marking solutions with value-added benefits for the healthcare industry. Founding member with expertise in functional labels for injection devices including first-opening indication and RFID.
- Körber PharmacoreOffers innovative, high-quality and sustainable pharma packaging solutions with customized Rondo and Dividella Solutions for monomaterial packaging. Founding member providing secondary packaging expertise.
- SCHOTT PharmacoreGlobal leading manufacturer in primary packaging for pharmaceuticals, producing annually more than 11 billion vials, ampoules, cartridges and syringes. Represented in 34 countries. Founding member providing primary packaging expertise and home of the current President (Dr. Arne Kloke).
- DatwylercoreFocuses on high-quality, system-critical elastomer components with leading positions in healthcare, mobility, and food & beverage. Headquartered in Switzerland with more than 20 operating companies and sales in over 100 countries. Founding member providing elastomer component expertise.
- YpsomedcoreLeading developer and manufacturer of injection and infusion systems for self-medication and diabetes specialist with over 35 years' experience. Provides pens, auto injectors and infusion systems. Founding member providing drug delivery device expertise.
- HealthBeaconminorHealthcare technology company providing smart injection device management. Home of Marion Briggs, former Vice President of Alliance to Zero. Specializes in sustainability and Green Labs facility processing injection waste in a more circular manner.
Scale indicators3 records
Recent moves8 records
Expansion highlights4 records
Alliance to Zero competitors and assessment
Company assessmentOthers
- CDP (Carbon Disclosure Project): A global disclosure system for environmental impacts, including pharma supply chain reporting. Comparable as the data and disclosure infrastructure that the Alliance's PCF methodologies feed into for Scope 1–3 reporting and supply chain transparency.
- Resourcify: A circular economy software platform for digitized waste management and closed-loop recycling programs. Comparable because it is the Alliance's newest member and a representative of the digital circularity tooling category that supports pharma device take-back and recycling.
- Science Based Targets initiative (SBTi): A partnership organization defining and promoting best practice in science-based target setting for emissions reductions. Comparable because Alliance to Zero members (e.g., Körber) adopt SBTi-aligned roadmaps and the Alliance's PCF guidance supports SBTi target fulfillment across pharma.
Direct peers
- Pharmaceutical Supply Chain Initiative (PSCI): A non-profit, member-driven consortium of pharmaceutical and healthcare companies that promotes responsible supply chain practices, including environmental sustainability. Directly comparable as a pre-competitive pharma supply chain collaboration model that produces shared principles and audit frameworks.
- AMR Industry Alliance: A coalition of biotech, diagnostics, generics, and research-based pharmaceutical companies that addresses antimicrobial resistance and broader sustainability across the value chain. Comparable as a pharma industry consortium producing shared sustainability guidance and engaging in regulatory advocacy.
Emerging players
- Manufacture 2030: A supply-chain sustainability platform helping manufacturers and their suppliers measure, report, and reduce carbon emissions and other environmental impacts. Comparable as it provides Scope 1–3 emissions data and decarbonization programs applicable to pharmaceutical supply chain participants.
Broad incumbents
- European Federation of Pharmaceutical Industries and Associations (EFPIA): The European pharma industry association representing R&D-based companies, with active sustainability and supply chain programs. Comparable as the EU-level industry body that competes with the Alliance for influence on EU circularity and decarbonization policy.
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): The global trade association representing the research-based pharmaceutical industry, with sustainability and climate initiatives for the broader pharma sector. Comparable as the highest-level industry body whose agendas shape the operating context for Alliance to Zero's specialty work.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Alliance to Zero social profiles
Digital presenceAlliance to Zero financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alliance to Zero leadership team
Management profileNumber of profiles
Profiles10 records
Alliance to Zero funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alliance to Zero M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alliance to Zero
What does Alliance to Zero do?
Alliance to Zero is a non-profit membership association that brings together pharmaceutical and biotech supply chain companies to collaboratively develop methodologies, guidelines, and solutions for decarbonizing the sector. Its deliverables include the PCF Guideline for carbon footprint assessment of injection devices, ecodesign principles for injectors and machinery, circular economy frameworks, whitepapers on sustainable plastics, and co-developed innovations such as the Secure Blister-Free Syringe (SBFS) packaging solution.
Is Alliance to Zero a public or private company?
Alliance to Zero is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Alliance to Zero founded?
Alliance to Zero was founded in 2021. It employs 11 to 50 people.
Where is Alliance to Zero based?
Alliance to Zero is headquartered in Burgdorf, Switzerland, in the Europe region.
Who are Alliance to Zero's main competitors?
Others on record are CDP (Carbon Disclosure Project), Resourcify and Science Based Targets initiative (SBTi). Direct peers are Pharmaceutical Supply Chain Initiative (PSCI) and AMR Industry Alliance. Manufacture 2030 is listed as an emerging player. Broad incumbents are European Federation of Pharmaceutical Industries and Associations (EFPIA) and International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
Does Alliance to Zero have an API?
No public API is recorded for Alliance to Zero.
What industry is Alliance to Zero in?
Alliance to Zero's product category is Pharmaceutical Supply Chain Sustainability Association. Its primary akta.pro industry code is EUABAKAC, Decarbonization Strategy & Marginal Abatement Cost Curve (MACC) Advisory, with a secondary code of EUABAKAD, Scope 1–3 GHG Inventory Strategy, Data Governance & Controls (advisory). Its NAICS code is 813910 and its SIC code is 8600.